These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infection of epithelial cells with dengue virus promotes the expression of proteins favoring the replication of certain viral strains. Martínez-Betancur V; Marín-Villa M; Martínez-Gutierrez M J Med Virol; 2014 Aug; 86(8):1448-58. PubMed ID: 24374781 [TBL] [Abstract][Full Text] [Related]
7. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. Puerta-Guardo H; Raya-Sandino A; González-Mariscal L; Rosales VH; Ayala-Dávila J; Chávez-Mungía B; Martínez-Fong D; Medina F; Ludert JE; del Angel RM J Virol; 2013 Jul; 87(13):7486-501. PubMed ID: 23616663 [TBL] [Abstract][Full Text] [Related]
8. RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation. Campos RK; Wong B; Xie X; Lu YF; Shi PY; Pompon J; Garcia-Blanco MA; Bradrick SS J Virol; 2017 Feb; 91(4):. PubMed ID: 27974556 [TBL] [Abstract][Full Text] [Related]
9. The Role of Autophagy-Mediated Dengue Virus Antibody-Dependent Enhancement Infection of THP-1 Cells. Jiang L; Sun Q Intervirology; 2020; 63(1-6):57-65. PubMed ID: 33202415 [TBL] [Abstract][Full Text] [Related]
14. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. Chareonsirisuthigul T; Kalayanarooj S; Ubol S J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552 [TBL] [Abstract][Full Text] [Related]
15. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection. Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366 [TBL] [Abstract][Full Text] [Related]
16. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection. Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500 [TBL] [Abstract][Full Text] [Related]
17. Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells. Asad S; Feitosa-Suntheimer F; Gold A; Londono-Renteria B; Colpitts TM J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735189 [TBL] [Abstract][Full Text] [Related]
18. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection. Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769 [TBL] [Abstract][Full Text] [Related]
19. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine. Shukla R; Ramasamy V; Shanmugam RK; Ahuja R; Khanna N Front Cell Infect Microbiol; 2020; 10():572681. PubMed ID: 33194810 [TBL] [Abstract][Full Text] [Related]
20. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts. Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]